MannKind Corporation
- MNKD
- NASDAQ
- Biotechnology
- Inhaled Insulin (Afrezza)
$3.04
Today −4.70%Quote Oct 16, 2026, 08:00 PM UTC
−15.08%over the last month
Max drawdown −23.5%From 1-month high −23.0%3 months −23.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$977.5M
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$10.00
+228.9% from here
Floor
$3.00
1.4% below price
Where the price sits
21 analysts
Analyst range, low to high
$7.00$13.00
- Price $3.04
- Resistance $3.06
- Consensus $10.00
The price is just above its floor and right under resistance. Analysts' average target sits about 229% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MNKDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $109.4M
- Product Revenue$71.6M65.4%
- Royalty$32.4M29.6%
- Service$5.4M5.0%
Industry
Biotechnology
Employees
592